« Back
Home /
Brimonidine Tartrate

Brimonidine Tartrate

Item no.	TMO-T6422-200mg
Manufacturer	TargetMol
CASRN	70359-46-5
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9983
Citations	1. WoldeMussie E, et al. Invest Ophthalmol Vis Sci, 2001, 42(12), 2849-2855.
Smiles	O[C@H]([C@@H](O)C(O)=O)C(O)=O.Brc1c(NC2=NCCN2)ccc2nccnc12
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	AGN190342 tartrate,AGN190342 (tartrate),UK 14304 (tartrate),UK14304 tartrate
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Adrenergic Receptor
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	442.22
Description	Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
Pathways	GPCR/G Protein\|\|\|Neuroscience
Bioactivity	Brimonidine tartrate is a quinoxaline derivative and adrenergic alpha-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
Receptor	alpha2A-adrenergic receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6422-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question